Elanco Animal Health Inc balance sheet

At the end of fiscal 2025, Elanco Animal Health Inc had total assets of $13.36bn, total liabilities of $6.81bn and shareholders' equity of $6.55bn. It held $545m in cash against $4.02bn of debt: net debt of $3.47bn.

Balance sheet

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Elanco Animal Health Inc: balance sheet, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	0.3	0.3	0.5	0.3	0.5	0.6	0.3	0.4	0.5	0.5	0.5
Receivables	—	0.6	0.7	0.8	0.9	0.8	0.8	0.8	0.8	0.9	1.1
Inventory	—	1.1	1.0	1.1	1.6	1.4	1.5	1.7	1.6	1.7	1.8
Total current assets	—	2.1	2.5	2.4	3.4	3.3	3.3	3.4	3.2	3.5	3.8
Goodwill	—	3.0	3.0	3.0	6.2	6.2	6.0	5.1	4.4	4.8	4.8
Total assets	—	8.9	9.0	9.0	17.7	16.5	15.5	14.4	12.6	13.4	13.6
Accounts payable	—	0.2	0.2	0.2	0.5	0.4	0.4	0.3	0.3	0.4	0.4
Deferred revenue (current)	—	0.2	0.2	0.2	0.3	0.3	0.3	0.4	0.3	0.4	0.5
Total current liabilities	—	0.6	1.0	0.8	2.1	1.6	1.7	1.2	1.3	1.6	1.9
Short-term debt	—	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.0	—	—
Long-term debt	—	0.0	2.4	2.3	5.6	6.0	5.4	5.7	4.3	3.8	3.7
Total debt	0.0	0.0	2.5	2.4	6.2	6.4	5.9	5.8	4.3	4.0	3.9
Total liabilities	—	1.2	3.8	3.4	9.2	9.0	8.2	8.1	6.5	6.8	7.0
Shareholders' equity	7.0	7.8	5.2	5.5	8.5	7.5	7.3	6.2	6.1	6.5	6.6
Net debt (negative = net cash)	−0.3	−0.3	2.0	2.0	5.7	5.8	5.6	5.5	3.9	3.5	3.4
Shares outstanding	—	366m	366m	373m	472m	473m	474m	493m	494m	497m	500m

US$ billions unless shown otherwise. Fiscal quarters.

Elanco Animal Health Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	0.8	0.8	1.0	1.0	0.9	0.9	1.1	1.1
Inventory	1.6	1.6	1.6	1.7	1.7	1.7	1.7	1.8
Total current assets	3.4	3.2	3.4	3.6	3.5	3.5	3.6	3.8
Goodwill	4.6	4.4	4.5	4.8	4.8	4.8	4.7	4.8
Total assets	13.3	12.6	12.9	13.7	13.6	13.4	13.2	13.6
Accounts payable	0.3	0.3	0.3	0.4	0.4	0.4	0.4	0.4
Deferred revenue (current)	0.3	0.3	0.3	0.4	0.4	0.4	0.4	0.5
Total current liabilities	1.3	1.3	1.3	1.4	1.5	1.6	1.7	1.9
Short-term debt	0.0	0.0	0.0	—	—	—	—	—
Long-term debt	4.3	4.3	4.4	4.0	3.8	3.8	3.7	3.7
Total debt	4.4	4.3	4.4	4.0	3.8	3.8	3.7	3.7
Total liabilities	6.8	6.5	6.6	7.0	6.8	6.8	6.7	7.0
Shareholders' equity	6.5	6.1	6.4	6.8	6.7	6.5	6.5	6.6
Shares outstanding	494m	494m	496m	497m	497m	497m	499m	500m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ELAN vs JAZZ ELAN vs OGN AMRX vs ELAN

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Elanco Animal Health Inc's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Elanco Animal Health Inc.